Bone Morphogenetic Protein Market - Forecast(2021 - 2026)

Report Code: HCR 96443 Report Format: PDF + Excel (Delivery in 48 Hrs)

Bone Morphogenetic Protein Market Overview

Bone Morphogenetic Protein Market size is estimated to reach $3,700 million by 2026, growing at a CAGR of 6.1% over 2021-2026. Bone morphogenetic are also known as cytokines that helps to maintain and cartilage and ideal to insert specific cells and from a new bone. Bone morphogenetic protein are naturally occurring proteins that are involved in various cellular responses and belong to beta super family. It is used in various orthopedic application such as spinal fusions and oral surgery and are useful for the spinal infusion treatment. This is also called as rh-BMP-7 which helps in the treatment of kidney disease. Bone morphogenetic also plays an important role in the development of central nervous system. Growing prevalence of minimally invasive procedures and increasing technological development in the field of bone morphogenetic protein is the major factor driving the growth of this market. Furthermore, increasing research and development activities in healthcare industry is set to further enhance the overall market demand for Bone Morphogenetic Protein Market for the period 2021-2026.

Report Coverage

The report: “Bone Morphogenetic Protein Market Forecast (2021-2026)”, by IndustryARC, covers an in-depth analysis of the following segments of the Bone Morphogenetic Protein Market.
By Type: rh-BMP-2, and rh-BMP-7
By Application: Spinal Fusion, Trauma, Reconstruction, and Oral Maxillofacial
By Geography: North America (U.S., Canada, Mexico), Europe (U.K, Germany, Italy, France, Spain, Russia, Rest of Europe), Asia Pacific (China, Australia, Japan, South Korea, India, Rest of Asia Pacific), South America (Brazil, Argentina, Others) and Rest of the World (Middle East, Africa)

Key Takeaways

  • Geographically, in 2020, North America dominated the Bone Morphogenetic Protein Market owing to growing advancement in technology, rising healthcare infrastructure and increasing R&D initiatives for the development of bone morphogenetic protein.
  • Growing prevalence of minimally invasive procedures and increasing technological development in the field of bone morphogenetic protein are likely to aid in the market growth of the Bone Morphogenetic Protein. 
  • Detailed analysis of the Strength, Weakness, and Opportunities of the prominent manufacturers operating in the market will be provided in the Bone Morphogenetic Protein Market final report. 
  • High cost of procedure is set to create hurdles for the Bone Morphogenetic Protein Market.

Bone Morphogenetic Protein Market Size, By Application 2020-2026 (USD Million)
Bone Morphogenetic Protein Market
For More Details on This Report - Request for Sample

Bone Morphogenetic Protein Segment Analysis – By Type

The Bone Morphogenetic Protein Market based on Type can be further segmented into rh-BMP-2, and rh-BMP-7. The rh-BMP-2 segment is the major segment generating revenue in 2020. This is mainly owing to increasing adoption of this protein by the physicians and surgeons owing to growing number of sports injuries that increases the demand of rh-BMP-2 and are increasing the growth of this market. The rh-BMP-7 segment is estimated to register the fastest CAGR of 1.05% for the period 2021-2026. This is mainly owing to the effective results in bone grafting that increases the need of rh-BMP-7 and are expanding the growth of this market. 

Bone Morphogenetic Protein Segment Analysis – By Application

The Bone Morphogenetic Protein Market based on Application can be further segmented into Spinal Fusion, Trauma, Reconstruction, and Oral Maxillofacial. The Spinal Fusion segment registers for the highest Lemon Extract market share in 2020. Bone morphogenetic protein (BMP) is a kind of protein that are widely used in spinal fusion surgery as it helps to reduce complications of an iliac crest autograft that increases the demand of this segment and are rising the growth of this market. The Trauma segment is forecasted to register the fastest CAGR of 2% over 2021-2026. This is mainly owing to bone morphogenetic proteins helps recruiting bone-forming cells to the area of trauma that are rising the growth of this market.

Bone Morphogenetic Protein Segment Analysis – By Geography

North America dominated the Market with major share of 40% in 2020. This is owing to growing advancement in technology, rising healthcare infrastructure and increasing R&D initiatives for the development of bone morphogenetic protein. According to National Spinal Cord Injury Center, more than 17,730 cases of spinal cord injuries occur in U.S. in 2019 that increases the growth of this market.

However, Asia Pacific is estimated to outpace all the regions by clocking the highest CAGR of 3.05% during the forecast period 2021-2026 owing to rising geriatric population and increasing research and development activities in healthcare industry.

Bone Morphogenetic Protein Market Drivers

Growing Prevalence of Minimally Invasive Procedures

Increasing sports related injuries are leading to the prevalence of minimally invasive surgeries that increases the growth of this market. Moreover, rising geriatric population and increasing number of accidents also increases the demand of minimally invasive procedures that helps to expand the growth of the Bone Morphogenetic Protein Market over 2021-2026.

Increasing Technological Development

Increasing technological development in the field of bone morphogenetic protein increases the growth of this Market. Various companies such as Stemgen s.p.a are offering technology such as hrBMP4 that increasing the growth of Bone Morphogenetic Protein Market over 2021-2026.

Covid-19 Impact: 

COVID-19 pandemic had greatly impacted the growth of Bone Morphogenetic Protein Market. Owing to shut down in the manufacturing units, there is an acute shortage in the supply of raw materials that reduces the sales and reduces the growth of health care research and development and are negatively impacted the growth of this market.

Bone Morphogenetic Protein Market Challenges

High Cost of Procedure

The factors that is set to impede the growth of the Bone Morphogenetic Market are the high cost of procedure and availability of alternative treatments is set to create hurdles for the Bone Morphogenetic protein Market. 

Bone Morphogenetic Protein Landscape

Product launches, acquisitions, collaboration, joint ventures, and geographical expansions are key strategies adopted by players in the Bone Morphogenetic protein Market. Bone Morphogenetic protein top 10 companies are Medtronic, Cellumed Co.,Ltd, Sigma-Aldrich Corporation, ProSpec, Ember Therapeutics, DePuy Synthesis, and Others.

Development

  • In September 2019, Medtronic received FDA approval for the use of Infuse bone graft that allow the usage of bone graft for Transforaminal Lumbar Interbody Fusion (TLIF) spine procedures.

Relevant Reports:

Report Code: HCR 46946

Report Code: HCR 67843

For more Lifesciences and Healthcare Market reports, please click here
1. Bone Morphogenetic Protein Market Overview
    1.1 Definitions and Scope
2. Bone Morphogenetic Protein Market Executive Summary
    2.1 Market Size and Key Trends 
    2.2 Key trends by Type
    2.3 Key trends by Application
    2.4 Key trends by Geography
3. Bone Morphogenetic Protein Market Landscape
    3.1 Market Share Analysis- Key Companies
    3.2 Product Benchmarking- Key Companies
    3.3 Financial Analysis - Key Companies
    3.4 Patent Analysis 
    3.5 Pricing Analysis
4. Bone Morphogenetic Protein Market - Startup companies Scenario Premium Premium
    4.1 Key startup company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Application Analysis
        4.1.4 Venture Capital and Funding Scenario
5. Bone Morphogenetic Protein Market- Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of successful ventures
6. Bone Morphogenetic Protein Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining Power of Suppliers
        6.3.2 Bargaining Powers of Customers
        6.3.3 Threat of New Entrants
        6.3.4 Rivalry Among Existing Players
        6.3.5 Threat of Substitutes 
7. Bone Morphogenetic Protein Market Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Bone Morphogenetic Protein Market – By Type (Market Size -$Million/$Billion)
    8.1 rh-BMP-2
    8.2 rh-BMP-7
9. Bone Morphogenetic Protein Market– By Application (Market Size -$Million/$Billion) 
    9.1 Spinal Fusion
    9.2 Trauma
    9.3 Reconstruction
    9.4 Oral Maxillofacial
10. Bone Morphogenetic Protein Market- By Geography (Market Size -$Million/$Billion)
    10.1 North America
        10.1.1 U.S.
        10.1.2 Canada
        10.1.3 Mexico
    10.2 Europe
        10.2.1 U.K.
        10.2.2 Germany
        10.2.3 Italy
        10.2.4 France
        10.2.5 Spain
        10.2.6 Russia
        10.2.7 Rest of Europe
    10.3 Asia-Pacific
        10.3.1 China
        10.3.2 Australia
        10.3.3 Japan
        10.3.4 South Korea
        10.3.5 India
        10.3.6 Rest of Asia-Pacific
    10.4 South America
        10.4.1 Brazil 
        10.4.2 Argentina
        10.4.3 Others
    10.5 Rest of the World
        10.5.1 Middle East
        10.5.2 Africa
11. Bone Morphogenetic Protein Market Entropy
12. Bone Morphogenetic Protein Market- Industry / Segment Competition landscape Premium Premium
    12.1 Market Share Analysis
        12.1.1 Market Share by Country- Key companies
        12.1.2 Market Share by Region- Key companies
        12.1.3 Market Share at Global Level- Key companies
        12.1.4 Best Practices for Companies
13. Bone Morphogenetic Protein Market- Key Company List by Country Premium Premium
14. Bone Morphogenetic Protein Market Company Analysis 
    14.1 Company Revenue, Products, M&A, Developments
    14.2 Company 1 
    14.3 Company 2
    14.4 Company 3
    14.5 Company 4
    14.6 Company 5
    14.7 Company 6
    14.8 Company 7
    14.9 Company 8
    14.10 Company 9
    14.11 Company 10
"*Financials for private companies would be provided on a best efforts basis”.

List of Tables

1 US Bone Morphogenetic Protein Market Size 2018
2 Canada Bone Morphogenetic Protein Market Share 2018
3 Brazil Bone Morphogenetic Protein Market Outlook 2019 - 2023
4 Mexico Bone Morphogenetic Protein Market Research 2018
5 Germany Bone Morphogenetic Protein Market Trends 2019 - 2023 
6 France Bone Morphogenetic Protein Market Growth 2019 - 2023 
7 UK Bone Morphogenetic Protein Market Demand 2019 - 2023 
8 Italy Bone Morphogenetic Protein Market Segmentation 2018
9 Russia Bone Morphogenetic Protein Market Analysis 2019 - 2023
10 China Bone Morphogenetic Protein Market Revenue 2019 - 2023
11 Japan Bone Morphogenetic Protein Market Volume 2019 - 2023
12 South Korea Bone Morphogenetic Protein Market Potential 2019 - 2023
13 India Bone Morphogenetic Protein Market Leaders 2018
14 Saudi Arabia Bone Morphogenetic Protein Market Forecast 2019 - 2023 
15 Kuwait Bone Morphogenetic Protein Market Value 2018

List of Figures

For complete list of 60+ tables and 60+ figures follow the Link